Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GRCL

Gracell Biotechnologies (GRCL) Stock Price, News & Analysis

Gracell Biotechnologies logo

About Gracell Biotechnologies Stock (NASDAQ:GRCL)

Advanced Chart

Key Stats

Today's Range
$10.25
$10.25
50-Day Range
$10.14
$10.35
52-Week Range
$1.40
$10.44
Volume
N/A
Average Volume
1.32 million shs
Market Capitalization
$744.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GRCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GRCL Stock News Headlines

GRCL Mar 2024 10.000 call(CONTR
Gracell Biotechnologies Acquisition Completed
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Gracell Biotechnologies Acquisition Completed
Gracell Biotechnologies Inc. (GRCL)
See More Headlines

GRCL Stock Analysis - Frequently Asked Questions

Gracell Biotechnologies Inc. (NASDAQ:GRCL) announced its quarterly earnings results on Sunday, November, 14th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.18. The business had revenue of $0.06 million for the quarter.

Gracell Biotechnologies (GRCL) raised $150 million in an initial public offering (IPO) on Friday, January 8th 2021. The company issued 8,800,000 shares at a price of $16.00-$18.00 per share. Citigroup, Jefferies, Piper Sandler and Wells Fargo Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gracell Biotechnologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

Last Earnings
11/14/2021
Today
9/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:GRCL
CIK
1826492
Fax
N/A
Employees
314
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$88.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-37.40%
Return on Assets
-31.24%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
7.73
Quick Ratio
7.73

Sales & Book Value

Annual Sales
$60 thousand
Price / Sales
12,415.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.95 per share
Price / Book
3.47

Miscellaneous

Outstanding Shares
72,678,000
Free Float
52,328,000
Market Cap
$744.95 million
Optionable
Optionable
Beta
-0.33

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:GRCL) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners